2015
DOI: 10.1007/8623_2015_60
|View full text |Cite
|
Sign up to set email alerts
|

Methods for Recombinant Rhamnolipid Production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
1
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 36 publications
0
8
0
Order By: Relevance
“…Quantification of HAAs. For HAA quantification, components of the samples were separated using reverse-phase chromatography on a C 18 column and detected with a charged aerosol detector (RP-HPLC-CAD) as described by Tiso et al (60), based on the method established by Behrens et al (61). Harvesting of cells and cell residue was accomplished by centrifugation at 13,000 ϫ g for 3 min.…”
Section: Discussionmentioning
confidence: 99%
“…Quantification of HAAs. For HAA quantification, components of the samples were separated using reverse-phase chromatography on a C 18 column and detected with a charged aerosol detector (RP-HPLC-CAD) as described by Tiso et al (60), based on the method established by Behrens et al (61). Harvesting of cells and cell residue was accomplished by centrifugation at 13,000 ϫ g for 3 min.…”
Section: Discussionmentioning
confidence: 99%
“…The natural RL producer P. aeruginosa is an opportunistic human pathogen entailing a complex regulation, which limits industrial application (Gunther et al, 2005). To overcome this restriction, the safety‐level‐1‐organism P. putida KT2440, which is an industrially relevant microorganism, was genetically modified to produce RL by introducing two required genes from P. aeruginosa (Tiso et al, 2015, 2017; Wittgens et al, 2011). RL production from hydrophilic substrates like glucose or xylose with P. putida was shown before (Bator et al, 2020; Tiso et al, 2020), drastically improving the downstream process in contrast to hydrophobic substrates like plant oils, which are often used for RL synthesis by P. aeruginosa (Wittgens et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Not surprisingly, the low-hanging fruits are to be found in the realm of metabolic engineering, a field that is well familiar with the use of bacteria other than E. coli as platforms for synthesis of added-value products. The panel of cases examined below go from biosynthesis of bulk chemicals such as isoprenoids [29], esters [30] and rhamnolipids [31], to biotransformations for adding value to common substrates [32] and finally to produce more sophisticated molecules like lantibiotics [33]. New materials with awesome properties can also be produced by deeply refactored bacteria [34].…”
Section: Discussionmentioning
confidence: 99%